Global Liposomes Drug Delivery Market Data Survey Report 2025
Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Major applications as follows:
Regional market size, production data and export & import:
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- Johnson & Johnson
- Gilead Sciences
- Luye Pharma
- Sun Pharmaceutical
- Pacira
- Fudan-Zhangjiang
- Sigma-Tau Group
- Teva Pharmaceutical
- CSPC
- Novartis
- Crucell
- Celsion Corporation
- Kingond Pharm
- Shanghai New Asia
- Spectrum Pharmaceuticals
Major applications as follows:
- Liposomal doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
Regional market size, production data and export & import:
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Johnson & Johnson
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Gilead Sciences
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Luye Pharma
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sun Pharmaceutical
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Pacira
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Fudan-Zhangjiang
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sigma-Tau Group
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Teva Pharmaceutical
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 CSPC
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Novartis
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Crucell
3.12 Celsion Corporation
3.13 Kingond Pharm
3.14 Shanghai New Asia
3.15 Spectrum Pharmaceuticals
4 MAJOR APPLICATION
4.1 Liposomal doxorubicin
4.1.1 Overview
4.1.2 Liposomal doxorubicin Market Size and Forecast
4.2 Liposomal Amphoteracin B
4.2.1 Overview
4.2.2 Liposomal Amphoteracin B Market Size and Forecast
4.3 Liposomal Paclitaxel
4.3.1 Overview
4.3.2 Liposomal Paclitaxel Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Johnson & Johnson
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Gilead Sciences
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Luye Pharma
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Sun Pharmaceutical
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Pacira
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Fudan-Zhangjiang
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sigma-Tau Group
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Teva Pharmaceutical
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 CSPC
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Novartis
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Crucell
3.12 Celsion Corporation
3.13 Kingond Pharm
3.14 Shanghai New Asia
3.15 Spectrum Pharmaceuticals
4 MAJOR APPLICATION
4.1 Liposomal doxorubicin
4.1.1 Overview
4.1.2 Liposomal doxorubicin Market Size and Forecast
4.2 Liposomal Amphoteracin B
4.2.1 Overview
4.2.2 Liposomal Amphoteracin B Market Size and Forecast
4.3 Liposomal Paclitaxel
4.3.1 Overview
4.3.2 Liposomal Paclitaxel Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
LIST OF TABLES
TAB REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences
Tab Sales Revenue, Volume, Price, Cost and Margin of Luye Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Sun Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Pacira
Tab Sales Revenue, Volume, Price, Cost and Margin of Fudan-Zhangjiang
Tab Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of CSPC
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Crucell
Tab Sales Revenue, Volume, Price, Cost and Margin of Celsion Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Kingond Pharm
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai New Asia
Tab Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
TAB REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead Sciences
Tab Sales Revenue, Volume, Price, Cost and Margin of Luye Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Sun Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Pacira
Tab Sales Revenue, Volume, Price, Cost and Margin of Fudan-Zhangjiang
Tab Sales Revenue, Volume, Price, Cost and Margin of Sigma-Tau Group
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of CSPC
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Crucell
Tab Sales Revenue, Volume, Price, Cost and Margin of Celsion Corporation
Tab Sales Revenue, Volume, Price, Cost and Margin of Kingond Pharm
Tab Sales Revenue, Volume, Price, Cost and Margin of Shanghai New Asia
Tab Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
LIST OF FIGURES
Fig Global Liposomes Drug Delivery Market Size and CAGR 2011-2017 (Value)
Fig Global Liposomes Drug Delivery Market Size and CAGR 2011-2017 (Volume)
Fig Global Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Value)
Fig Global Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal doxorubicin Market Size and CAGR 2011-2017 (Value)
Fig Liposomal doxorubicin Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal doxorubicin Market Forecast and CAGR 2018-2025 (Value)
Fig Liposomal doxorubicin Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Value)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Value)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Value)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Value)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Fig Global Liposomes Drug Delivery Market Size and CAGR 2011-2017 (Value)
Fig Global Liposomes Drug Delivery Market Size and CAGR 2011-2017 (Volume)
Fig Global Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Value)
Fig Global Liposomes Drug Delivery Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal doxorubicin Market Size and CAGR 2011-2017 (Value)
Fig Liposomal doxorubicin Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal doxorubicin Market Forecast and CAGR 2018-2025 (Value)
Fig Liposomal doxorubicin Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Value)
Fig Liposomal Amphoteracin B Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Value)
Fig Liposomal Amphoteracin B Market Forecast and CAGR 2018-2025 (Volume)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Value)
Fig Liposomal Paclitaxel Market Size and CAGR 2011-2017 (Volume)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Value)
Fig Liposomal Paclitaxel Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
